veliparib

Results from Clinical Trial of Veliparib for People with Unmethylated Glioblastoma Bookmark

This scientific report from Neuro-Oncology outlines findings from a large, randomized clinical trial showing that the drug veliparib (a kind of drug known as a PARP inhibitor) added to radiotherapy and temozolomide did not improve progression-free survival in unmethylated glioblastoma.

.